Clinical Trial Details


Back to Clinical Trials Database

Combination of targeted therapy (Encorafenib and Binimetinib) followed by combination of immunoterapy (Ipilimumab and Nivolumab) vs immediate combination of immunotherapy in patients with unresectable or metastatic melanoma with BRAF V600 mutation: an EORTC phase II randomized study (EBIN)

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 30-Oct-2018
Date Step1 close: 11-Jul-2022
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 270 - All Groups: 270
Treatment Drug
Ipilimumab, Nivolumab, Encorafenib, Binimetinib
Study Staff Caroline Robert (Study Coordinator) , Gustave Roussy, VILLEJUIF CEDEX
Hadi Almidani (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Emanuel Buhrer (Project Physician) , EORTC Headquarters, Brussels
Jose Casas (TR Scientist) , EORTC Headquarters, Brussels
Florence Dujardin (Data Manager) , EORTC Headquarters, Brussels
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Amaya Gonzalez (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels
Anne-Sophie Govaerts (Clinical Scientist) , EORTC Headquarters, Brussels
Lore Hermans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Sven Janssen (Data Manager) , EORTC Headquarters, Brussels
Michal Kicinski (Statistician) , EORTC Headquarters, Brussels
Robby Louis (Data Manager) , EORTC Headquarters, Brussels
Juliette Ly (Project Manager) , EORTC Headquarters, Brussels
Anja Mestnik (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Zara Nasir (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Barbara Ogrodniczak (Junior Clinical Operations Manager) , ,
Felix Oppong (Statistician) , EORTC Headquarters, Brussels
Miguel Remis (Lead CRA) , EORTC Headquarters, Brussels
Sandrine Rivrain (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Nathalie Ropson (Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Lien Styns (Data Manager) , EORTC Headquarters, Brussels
Carla Sureda (Clinical Operations Manager) , EORTC Headquarters, Brussels
Cathy Van de Wiele (Data Manager) , EORTC Headquarters, Brussels
Zineb Wadid (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels
Leen Wijnen (Data Manager) , EORTC Headquarters, Brussels
Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer Melanoma
Participating groups EORTC Melanoma Group
Recruiting centers APHP - Univ Paris Saclay - Hopital Ambroise Pare (Boulogne Billancourt, France)
APHP Nord - Univ De Paris Cite - Hop. Saint Louis (Paris, France)
Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale San Lazzaro (Torino, Italy)
Azienda Ospedaliera Papa Giovanni XXIII (Bergamo, Italy)
Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine (Udine, Italy)
CHRU de Besancon - Hopital Jean Minjoz (BESANCON CEDEX, France)
CHRU de Lille (LILLE CEDEX, France)
CHU Amiens Picardie - Site Sud (Amiens, France)
CHU Montpellier-Hopital St. Eloi (MONTPELLIER CEDEX 5, France)
CHU de Bordeaux - Groupe Hospitalier Saint-Andre - Hopital Saint-Andre (BORDEAUX CEDEX, France)
CHU de Grenoble - La Tronche - Hopital A. Michallon (GRENOBLE CEDEX 9, France)
CHU de Limoges - Hopital Dupuytren (LIMOGES CEDEX 1, France)
CHU de Lyon - Hopital Lyon Sud (PIERRE BENITE CEDEX, France)
CHU de Nice - Hopital De L'Archet (NICE, France)
CHU de Saint-Etienne - Hopital Nord (Saint Priest en Jarez, France)
CHU de Tours - Hopital Trousseau (Chambray Les tours, France)
CLCC - Jean Perrin (CLERMONT FERRAND , France)
Centre Georges-Francois-Leclerc (DIJON CEDEX, France)
Centre Hospitalier De Pau (PAU CEDEX, France)
Centre Leon Berard (Lyon, France)
Charite - Universitaetsmedizin Berlin - Campus Mitte (Berlin, Germany)
East and North Hertfordshire NHS Trust – Mount Vernon Hospital (Northwood, United Kingdom)
Elbe Kliniken - Buxtehude (Buxtehude, Germany)
Gustave Roussy (VILLEJUIF CEDEX, France)
Helsinki University Central Hospital - Dept of Oncology (Helsinki, Finland)
Herlev Hospital - University Copenhagen (Herlev, Denmark)
Hopital de La Timone (APHM) (MARSEILLE, France)
Hospital Clinic de Barcelona (Barcelona, Spain)
Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain)
Hospital Universitario La Paz (Madrid, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
IRCCS - Fondazione G. Pascale (Napoli, Italy)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
IRCCS-Regina Elena National Cancer Center (Roma, Italy)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
Odense University Hospital (Odense C, Denmark)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
Universita Degli Studi Di Siena -Policlinico "le Scotte" (Siena, Italy)
UniversitaetsMedizin Mannheim (Mannheim, Germany)
Universitaetsklinikum Heidelberg - Frauenklinik / Hautklinik (Heidelberg, Germany)
Universitaetsklinikum Wuerzburg (Wuerzburg, Germany)
Universitaetsklinikum Wuerzburg (Wuerzburg, Germany)
Universitaetsmedizin der Johannes Gutenberg Universitaet Mainz-University Medical Center (Mainz, Germany)
Protocol summary
NCT number NCT03235245
EudraCT 2017-002887-42
Financial Support Educational Grant